Shares of Wave Lifesciences WVE were up 8.26% on Sep 20, after the company announced a positive update from its ongoing phase Ib/IIa SELECT-HD study on its clinical candidate, WVE-009 for treating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results